Glenview, Icahn Face Off Over Cigna/Express Scripts Deal

(Bloomberg) -- Activist investor Carl Icahn’s push to derail Cigna Corp.’s proposed $54 billion takeover of pharmacy-benefits firm Express Scripts Holding Co. isn’t convincing one big shareholder.

Bloomberg Quint

Add BloombergQuint App to Home screen.